Global Monoclonal Antibodies for Plaque Psoriasis Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Monoclonal Antibodies for Plaque Psoriasis market size was valued at US$ 11930 million in 2025 and is forecast to a readjusted size of US$ 20590 million by 2032 with a CAGR of 8.2% during review period.
Monoclonal Antibodies for Plaque Psoriasis are a class of biological agents that specifically target key inflammatory mediators in psoriasis. These antibodies can precisely recognize and bind to targets such as interleukin-17 (IL-17), interleukin-23 (IL-23), or tumor necrosis factor-? (TNF-?), thereby effectively suppressing the inflammatory process and skin symptoms of psoriasis.
This report is a detailed and comprehensive analysis for global Monoclonal Antibodies for Plaque Psoriasis market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Monoclonal Antibodies for Plaque Psoriasis market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Monoclonal Antibodies for Plaque Psoriasis market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Monoclonal Antibodies for Plaque Psoriasis market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Monoclonal Antibodies for Plaque Psoriasis market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Monoclonal Antibodies for Plaque Psoriasis market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Monoclonal Antibodies for Plaque Psoriasis are a class of biological agents that specifically target key inflammatory mediators in psoriasis. These antibodies can precisely recognize and bind to targets such as interleukin-17 (IL-17), interleukin-23 (IL-23), or tumor necrosis factor-? (TNF-?), thereby effectively suppressing the inflammatory process and skin symptoms of psoriasis.
This report is a detailed and comprehensive analysis for global Monoclonal Antibodies for Plaque Psoriasis market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Monoclonal Antibodies for Plaque Psoriasis market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Monoclonal Antibodies for Plaque Psoriasis market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Monoclonal Antibodies for Plaque Psoriasis market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Monoclonal Antibodies for Plaque Psoriasis market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Monoclonal Antibodies for Plaque Psoriasis
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Monoclonal Antibodies for Plaque Psoriasis market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- 5-100 mg/mL
- 100-200 mg/mL
- Hospital
- Clinic
- Others
- Janssen Biotech, Inc.
- Biocon Ltd.
- Novartis AG
- Eli Lilly & Co.
- Bausch Health Cos., Inc
- Sun Pharmaceutical Industries Ltd.
- Almirall SA
- AbbVie, Inc.
- UCB, Inc.
- Chongqing Genrix Biopharmaceutical Co., Ltd
- Jiangsu Hengrui Pharmaceuticals Co., Ltd
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
- Chapter 1, to describe Monoclonal Antibodies for Plaque Psoriasis product scope, market overview, market estimation caveats and base year.
- Chapter 2, to profile the top manufacturers of Monoclonal Antibodies for Plaque Psoriasis, with price, sales quantity, revenue, and global market share of Monoclonal Antibodies for Plaque Psoriasis from 2021 to 2026.
- Chapter 3, the Monoclonal Antibodies for Plaque Psoriasis competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
- Chapter 4, the Monoclonal Antibodies for Plaque Psoriasis breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
- Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
- Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Monoclonal Antibodies for Plaque Psoriasis market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
- Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
- Chapter 13, the key raw materials and key suppliers, and industry chain of Monoclonal Antibodies for Plaque Psoriasis.
- Chapter 14 and 15, to describe Monoclonal Antibodies for Plaque Psoriasis sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 5-100 mg/mL
1.3.3 100-200 mg/mL
1.4 Market Analysis by Application
1.4.1 Overview: Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Monoclonal Antibodies for Plaque Psoriasis Market Size & Forecast
1.5.1 Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021 & 2025 & 2032)
1.5.2 Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (2021-2032)
1.5.3 Global Monoclonal Antibodies for Plaque Psoriasis Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Janssen Biotech, Inc.
2.1.1 Janssen Biotech, Inc. Details
2.1.2 Janssen Biotech, Inc. Major Business
2.1.3 Janssen Biotech, Inc. Monoclonal Antibodies for Plaque Psoriasis Product and Services
2.1.4 Janssen Biotech, Inc. Monoclonal Antibodies for Plaque Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Janssen Biotech, Inc. Recent Developments/Updates
2.2 Biocon Ltd.
2.2.1 Biocon Ltd. Details
2.2.2 Biocon Ltd. Major Business
2.2.3 Biocon Ltd. Monoclonal Antibodies for Plaque Psoriasis Product and Services
2.2.4 Biocon Ltd. Monoclonal Antibodies for Plaque Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Biocon Ltd. Recent Developments/Updates
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business
2.3.3 Novartis AG Monoclonal Antibodies for Plaque Psoriasis Product and Services
2.3.4 Novartis AG Monoclonal Antibodies for Plaque Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Novartis AG Recent Developments/Updates
2.4 Eli Lilly & Co.
2.4.1 Eli Lilly & Co. Details
2.4.2 Eli Lilly & Co. Major Business
2.4.3 Eli Lilly & Co. Monoclonal Antibodies for Plaque Psoriasis Product and Services
2.4.4 Eli Lilly & Co. Monoclonal Antibodies for Plaque Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Eli Lilly & Co. Recent Developments/Updates
2.5 Bausch Health Cos., Inc
2.5.1 Bausch Health Cos., Inc Details
2.5.2 Bausch Health Cos., Inc Major Business
2.5.3 Bausch Health Cos., Inc Monoclonal Antibodies for Plaque Psoriasis Product and Services
2.5.4 Bausch Health Cos., Inc Monoclonal Antibodies for Plaque Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Bausch Health Cos., Inc Recent Developments/Updates
2.6 Sun Pharmaceutical Industries Ltd.
2.6.1 Sun Pharmaceutical Industries Ltd. Details
2.6.2 Sun Pharmaceutical Industries Ltd. Major Business
2.6.3 Sun Pharmaceutical Industries Ltd. Monoclonal Antibodies for Plaque Psoriasis Product and Services
2.6.4 Sun Pharmaceutical Industries Ltd. Monoclonal Antibodies for Plaque Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
2.7 Almirall SA
2.7.1 Almirall SA Details
2.7.2 Almirall SA Major Business
2.7.3 Almirall SA Monoclonal Antibodies for Plaque Psoriasis Product and Services
2.7.4 Almirall SA Monoclonal Antibodies for Plaque Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Almirall SA Recent Developments/Updates
2.8 AbbVie, Inc.
2.8.1 AbbVie, Inc. Details
2.8.2 AbbVie, Inc. Major Business
2.8.3 AbbVie, Inc. Monoclonal Antibodies for Plaque Psoriasis Product and Services
2.8.4 AbbVie, Inc. Monoclonal Antibodies for Plaque Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 AbbVie, Inc. Recent Developments/Updates
2.9 UCB, Inc.
2.9.1 UCB, Inc. Details
2.9.2 UCB, Inc. Major Business
2.9.3 UCB, Inc. Monoclonal Antibodies for Plaque Psoriasis Product and Services
2.9.4 UCB, Inc. Monoclonal Antibodies for Plaque Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 UCB, Inc. Recent Developments/Updates
2.10 Chongqing Genrix Biopharmaceutical Co., Ltd
2.10.1 Chongqing Genrix Biopharmaceutical Co., Ltd Details
2.10.2 Chongqing Genrix Biopharmaceutical Co., Ltd Major Business
2.10.3 Chongqing Genrix Biopharmaceutical Co., Ltd Monoclonal Antibodies for Plaque Psoriasis Product and Services
2.10.4 Chongqing Genrix Biopharmaceutical Co., Ltd Monoclonal Antibodies for Plaque Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Chongqing Genrix Biopharmaceutical Co., Ltd Recent Developments/Updates
2.11 Jiangsu Hengrui Pharmaceuticals Co., Ltd
2.11.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd Details
2.11.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd Major Business
2.11.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd Monoclonal Antibodies for Plaque Psoriasis Product and Services
2.11.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd Monoclonal Antibodies for Plaque Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MONOCLONAL ANTIBODIES FOR PLAQUE PSORIASIS BY MANUFACTURER
3.1 Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Manufacturer (2021-2026)
3.2 Global Monoclonal Antibodies for Plaque Psoriasis Revenue by Manufacturer (2021-2026)
3.3 Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Monoclonal Antibodies for Plaque Psoriasis by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Monoclonal Antibodies for Plaque Psoriasis Manufacturer Market Share in 2025
3.4.3 Top 6 Monoclonal Antibodies for Plaque Psoriasis Manufacturer Market Share in 2025
3.5 Monoclonal Antibodies for Plaque Psoriasis Market: Overall Company Footprint Analysis
3.5.1 Monoclonal Antibodies for Plaque Psoriasis Market: Region Footprint
3.5.2 Monoclonal Antibodies for Plaque Psoriasis Market: Company Product Type Footprint
3.5.3 Monoclonal Antibodies for Plaque Psoriasis Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Monoclonal Antibodies for Plaque Psoriasis Market Size by Region
4.1.1 Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Region (2021-2032)
4.1.2 Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Region (2021-2032)
4.1.3 Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Region (2021-2032)
4.2 North America Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032)
4.3 Europe Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032)
4.4 Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032)
4.5 South America Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032)
4.6 Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2021-2032)
5.2 Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Type (2021-2032)
5.3 Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2021-2032)
6.2 Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Application (2021-2032)
6.3 Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2021-2032)
7.2 North America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2021-2032)
7.3 North America Monoclonal Antibodies for Plaque Psoriasis Market Size by Country
7.3.1 North America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Country (2021-2032)
7.3.2 North America Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2021-2032)
8.2 Europe Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2021-2032)
8.3 Europe Monoclonal Antibodies for Plaque Psoriasis Market Size by Country
8.3.1 Europe Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Country (2021-2032)
8.3.2 Europe Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Market Size by Region
9.3.1 Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2021-2032)
10.2 South America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2021-2032)
10.3 South America Monoclonal Antibodies for Plaque Psoriasis Market Size by Country
10.3.1 South America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Country (2021-2032)
10.3.2 South America Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Market Size by Country
11.3.1 Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Monoclonal Antibodies for Plaque Psoriasis Market Drivers
12.2 Monoclonal Antibodies for Plaque Psoriasis Market Restraints
12.3 Monoclonal Antibodies for Plaque Psoriasis Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Monoclonal Antibodies for Plaque Psoriasis and Key Manufacturers
13.2 Manufacturing Costs Percentage of Monoclonal Antibodies for Plaque Psoriasis
13.3 Monoclonal Antibodies for Plaque Psoriasis Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Monoclonal Antibodies for Plaque Psoriasis Typical Distributors
14.3 Monoclonal Antibodies for Plaque Psoriasis Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 5-100 mg/mL
1.3.3 100-200 mg/mL
1.4 Market Analysis by Application
1.4.1 Overview: Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Monoclonal Antibodies for Plaque Psoriasis Market Size & Forecast
1.5.1 Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021 & 2025 & 2032)
1.5.2 Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (2021-2032)
1.5.3 Global Monoclonal Antibodies for Plaque Psoriasis Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Janssen Biotech, Inc.
2.1.1 Janssen Biotech, Inc. Details
2.1.2 Janssen Biotech, Inc. Major Business
2.1.3 Janssen Biotech, Inc. Monoclonal Antibodies for Plaque Psoriasis Product and Services
2.1.4 Janssen Biotech, Inc. Monoclonal Antibodies for Plaque Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Janssen Biotech, Inc. Recent Developments/Updates
2.2 Biocon Ltd.
2.2.1 Biocon Ltd. Details
2.2.2 Biocon Ltd. Major Business
2.2.3 Biocon Ltd. Monoclonal Antibodies for Plaque Psoriasis Product and Services
2.2.4 Biocon Ltd. Monoclonal Antibodies for Plaque Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Biocon Ltd. Recent Developments/Updates
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business
2.3.3 Novartis AG Monoclonal Antibodies for Plaque Psoriasis Product and Services
2.3.4 Novartis AG Monoclonal Antibodies for Plaque Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Novartis AG Recent Developments/Updates
2.4 Eli Lilly & Co.
2.4.1 Eli Lilly & Co. Details
2.4.2 Eli Lilly & Co. Major Business
2.4.3 Eli Lilly & Co. Monoclonal Antibodies for Plaque Psoriasis Product and Services
2.4.4 Eli Lilly & Co. Monoclonal Antibodies for Plaque Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Eli Lilly & Co. Recent Developments/Updates
2.5 Bausch Health Cos., Inc
2.5.1 Bausch Health Cos., Inc Details
2.5.2 Bausch Health Cos., Inc Major Business
2.5.3 Bausch Health Cos., Inc Monoclonal Antibodies for Plaque Psoriasis Product and Services
2.5.4 Bausch Health Cos., Inc Monoclonal Antibodies for Plaque Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Bausch Health Cos., Inc Recent Developments/Updates
2.6 Sun Pharmaceutical Industries Ltd.
2.6.1 Sun Pharmaceutical Industries Ltd. Details
2.6.2 Sun Pharmaceutical Industries Ltd. Major Business
2.6.3 Sun Pharmaceutical Industries Ltd. Monoclonal Antibodies for Plaque Psoriasis Product and Services
2.6.4 Sun Pharmaceutical Industries Ltd. Monoclonal Antibodies for Plaque Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
2.7 Almirall SA
2.7.1 Almirall SA Details
2.7.2 Almirall SA Major Business
2.7.3 Almirall SA Monoclonal Antibodies for Plaque Psoriasis Product and Services
2.7.4 Almirall SA Monoclonal Antibodies for Plaque Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Almirall SA Recent Developments/Updates
2.8 AbbVie, Inc.
2.8.1 AbbVie, Inc. Details
2.8.2 AbbVie, Inc. Major Business
2.8.3 AbbVie, Inc. Monoclonal Antibodies for Plaque Psoriasis Product and Services
2.8.4 AbbVie, Inc. Monoclonal Antibodies for Plaque Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 AbbVie, Inc. Recent Developments/Updates
2.9 UCB, Inc.
2.9.1 UCB, Inc. Details
2.9.2 UCB, Inc. Major Business
2.9.3 UCB, Inc. Monoclonal Antibodies for Plaque Psoriasis Product and Services
2.9.4 UCB, Inc. Monoclonal Antibodies for Plaque Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 UCB, Inc. Recent Developments/Updates
2.10 Chongqing Genrix Biopharmaceutical Co., Ltd
2.10.1 Chongqing Genrix Biopharmaceutical Co., Ltd Details
2.10.2 Chongqing Genrix Biopharmaceutical Co., Ltd Major Business
2.10.3 Chongqing Genrix Biopharmaceutical Co., Ltd Monoclonal Antibodies for Plaque Psoriasis Product and Services
2.10.4 Chongqing Genrix Biopharmaceutical Co., Ltd Monoclonal Antibodies for Plaque Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Chongqing Genrix Biopharmaceutical Co., Ltd Recent Developments/Updates
2.11 Jiangsu Hengrui Pharmaceuticals Co., Ltd
2.11.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd Details
2.11.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd Major Business
2.11.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd Monoclonal Antibodies for Plaque Psoriasis Product and Services
2.11.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd Monoclonal Antibodies for Plaque Psoriasis Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: MONOCLONAL ANTIBODIES FOR PLAQUE PSORIASIS BY MANUFACTURER
3.1 Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Manufacturer (2021-2026)
3.2 Global Monoclonal Antibodies for Plaque Psoriasis Revenue by Manufacturer (2021-2026)
3.3 Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Monoclonal Antibodies for Plaque Psoriasis by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Monoclonal Antibodies for Plaque Psoriasis Manufacturer Market Share in 2025
3.4.3 Top 6 Monoclonal Antibodies for Plaque Psoriasis Manufacturer Market Share in 2025
3.5 Monoclonal Antibodies for Plaque Psoriasis Market: Overall Company Footprint Analysis
3.5.1 Monoclonal Antibodies for Plaque Psoriasis Market: Region Footprint
3.5.2 Monoclonal Antibodies for Plaque Psoriasis Market: Company Product Type Footprint
3.5.3 Monoclonal Antibodies for Plaque Psoriasis Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Monoclonal Antibodies for Plaque Psoriasis Market Size by Region
4.1.1 Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Region (2021-2032)
4.1.2 Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Region (2021-2032)
4.1.3 Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Region (2021-2032)
4.2 North America Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032)
4.3 Europe Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032)
4.4 Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032)
4.5 South America Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032)
4.6 Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2021-2032)
5.2 Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Type (2021-2032)
5.3 Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2021-2032)
6.2 Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Application (2021-2032)
6.3 Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2021-2032)
7.2 North America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2021-2032)
7.3 North America Monoclonal Antibodies for Plaque Psoriasis Market Size by Country
7.3.1 North America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Country (2021-2032)
7.3.2 North America Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2021-2032)
8.2 Europe Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2021-2032)
8.3 Europe Monoclonal Antibodies for Plaque Psoriasis Market Size by Country
8.3.1 Europe Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Country (2021-2032)
8.3.2 Europe Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Market Size by Region
9.3.1 Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2021-2032)
10.2 South America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2021-2032)
10.3 South America Monoclonal Antibodies for Plaque Psoriasis Market Size by Country
10.3.1 South America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Country (2021-2032)
10.3.2 South America Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Market Size by Country
11.3.1 Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Monoclonal Antibodies for Plaque Psoriasis Market Drivers
12.2 Monoclonal Antibodies for Plaque Psoriasis Market Restraints
12.3 Monoclonal Antibodies for Plaque Psoriasis Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Monoclonal Antibodies for Plaque Psoriasis and Key Manufacturers
13.2 Manufacturing Costs Percentage of Monoclonal Antibodies for Plaque Psoriasis
13.3 Monoclonal Antibodies for Plaque Psoriasis Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Monoclonal Antibodies for Plaque Psoriasis Typical Distributors
14.3 Monoclonal Antibodies for Plaque Psoriasis Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Janssen Biotech, Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Janssen Biotech, Inc. Major Business
Table 5. Janssen Biotech, Inc. Monoclonal Antibodies for Plaque Psoriasis Product and Services
Table 6. Janssen Biotech, Inc. Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Janssen Biotech, Inc. Recent Developments/Updates
Table 8. Biocon Ltd. Basic Information, Manufacturing Base and Competitors
Table 9. Biocon Ltd. Major Business
Table 10. Biocon Ltd. Monoclonal Antibodies for Plaque Psoriasis Product and Services
Table 11. Biocon Ltd. Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Biocon Ltd. Recent Developments/Updates
Table 13. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 14. Novartis AG Major Business
Table 15. Novartis AG Monoclonal Antibodies for Plaque Psoriasis Product and Services
Table 16. Novartis AG Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Novartis AG Recent Developments/Updates
Table 18. Eli Lilly & Co. Basic Information, Manufacturing Base and Competitors
Table 19. Eli Lilly & Co. Major Business
Table 20. Eli Lilly & Co. Monoclonal Antibodies for Plaque Psoriasis Product and Services
Table 21. Eli Lilly & Co. Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Eli Lilly & Co. Recent Developments/Updates
Table 23. Bausch Health Cos., Inc Basic Information, Manufacturing Base and Competitors
Table 24. Bausch Health Cos., Inc Major Business
Table 25. Bausch Health Cos., Inc Monoclonal Antibodies for Plaque Psoriasis Product and Services
Table 26. Bausch Health Cos., Inc Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Bausch Health Cos., Inc Recent Developments/Updates
Table 28. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 29. Sun Pharmaceutical Industries Ltd. Major Business
Table 30. Sun Pharmaceutical Industries Ltd. Monoclonal Antibodies for Plaque Psoriasis Product and Services
Table 31. Sun Pharmaceutical Industries Ltd. Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 33. Almirall SA Basic Information, Manufacturing Base and Competitors
Table 34. Almirall SA Major Business
Table 35. Almirall SA Monoclonal Antibodies for Plaque Psoriasis Product and Services
Table 36. Almirall SA Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Almirall SA Recent Developments/Updates
Table 38. AbbVie, Inc. Basic Information, Manufacturing Base and Competitors
Table 39. AbbVie, Inc. Major Business
Table 40. AbbVie, Inc. Monoclonal Antibodies for Plaque Psoriasis Product and Services
Table 41. AbbVie, Inc. Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. AbbVie, Inc. Recent Developments/Updates
Table 43. UCB, Inc. Basic Information, Manufacturing Base and Competitors
Table 44. UCB, Inc. Major Business
Table 45. UCB, Inc. Monoclonal Antibodies for Plaque Psoriasis Product and Services
Table 46. UCB, Inc. Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. UCB, Inc. Recent Developments/Updates
Table 48. Chongqing Genrix Biopharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 49. Chongqing Genrix Biopharmaceutical Co., Ltd Major Business
Table 50. Chongqing Genrix Biopharmaceutical Co., Ltd Monoclonal Antibodies for Plaque Psoriasis Product and Services
Table 51. Chongqing Genrix Biopharmaceutical Co., Ltd Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. Chongqing Genrix Biopharmaceutical Co., Ltd Recent Developments/Updates
Table 53. Jiangsu Hengrui Pharmaceuticals Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 54. Jiangsu Hengrui Pharmaceuticals Co., Ltd Major Business
Table 55. Jiangsu Hengrui Pharmaceuticals Co., Ltd Monoclonal Antibodies for Plaque Psoriasis Product and Services
Table 56. Jiangsu Hengrui Pharmaceuticals Co., Ltd Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 57. Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments/Updates
Table 58. Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 59. Global Monoclonal Antibodies for Plaque Psoriasis Revenue by Manufacturer (2021-2026) & (USD Million)
Table 60. Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 61. Market Position of Manufacturers in Monoclonal Antibodies for Plaque Psoriasis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 62. Head Office and Monoclonal Antibodies for Plaque Psoriasis Production Site of Key Manufacturer
Table 63. Monoclonal Antibodies for Plaque Psoriasis Market: Company Product Type Footprint
Table 64. Monoclonal Antibodies for Plaque Psoriasis Market: Company Product Application Footprint
Table 65. Monoclonal Antibodies for Plaque Psoriasis New Market Entrants and Barriers to Market Entry
Table 66. Monoclonal Antibodies for Plaque Psoriasis Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 68. Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Region (2021-2026) & (K Units)
Table 69. Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Region (2027-2032) & (K Units)
Table 70. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Region (2021-2026) & (USD Million)
Table 71. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Region (2027-2032) & (USD Million)
Table 72. Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Region (2021-2026) & (US$/Unit)
Table 73. Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Region (2027-2032) & (US$/Unit)
Table 74. Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2021-2026) & (K Units)
Table 75. Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2027-2032) & (K Units)
Table 76. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Type (2021-2026) & (USD Million)
Table 77. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Type (2027-2032) & (USD Million)
Table 78. Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Type (2021-2026) & (US$/Unit)
Table 79. Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Type (2027-2032) & (US$/Unit)
Table 80. Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2021-2026) & (K Units)
Table 81. Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2027-2032) & (K Units)
Table 82. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Application (2021-2026) & (USD Million)
Table 83. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Application (2027-2032) & (USD Million)
Table 84. Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Application (2021-2026) & (US$/Unit)
Table 85. Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Application (2027-2032) & (US$/Unit)
Table 86. North America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2021-2026) & (K Units)
Table 87. North America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2027-2032) & (K Units)
Table 88. North America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2021-2026) & (K Units)
Table 89. North America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2027-2032) & (K Units)
Table 90. North America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Country (2021-2026) & (K Units)
Table 91. North America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Country (2027-2032) & (K Units)
Table 92. North America Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Country (2021-2026) & (USD Million)
Table 93. North America Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Country (2027-2032) & (USD Million)
Table 94. Europe Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2021-2026) & (K Units)
Table 95. Europe Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2027-2032) & (K Units)
Table 96. Europe Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2021-2026) & (K Units)
Table 97. Europe Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2027-2032) & (K Units)
Table 98. Europe Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Country (2021-2026) & (K Units)
Table 99. Europe Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Country (2027-2032) & (K Units)
Table 100. Europe Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Country (2021-2026) & (USD Million)
Table 101. Europe Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Country (2027-2032) & (USD Million)
Table 102. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2021-2026) & (K Units)
Table 103. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2027-2032) & (K Units)
Table 104. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2021-2026) & (K Units)
Table 105. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2027-2032) & (K Units)
Table 106. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Region (2021-2026) & (K Units)
Table 107. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Region (2027-2032) & (K Units)
Table 108. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Region (2021-2026) & (USD Million)
Table 109. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Region (2027-2032) & (USD Million)
Table 110. South America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2021-2026) & (K Units)
Table 111. South America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2027-2032) & (K Units)
Table 112. South America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2021-2026) & (K Units)
Table 113. South America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2027-2032) & (K Units)
Table 114. South America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Country (2021-2026) & (K Units)
Table 115. South America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Country (2027-2032) & (K Units)
Table 116. South America Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Country (2021-2026) & (USD Million)
Table 117. South America Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Country (2027-2032) & (USD Million)
Table 118. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2021-2026) & (K Units)
Table 119. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2027-2032) & (K Units)
Table 120. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2021-2026) & (K Units)
Table 121. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2027-2032) & (K Units)
Table 122. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Country (2021-2026) & (K Units)
Table 123. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Country (2027-2032) & (K Units)
Table 124. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Country (2021-2026) & (USD Million)
Table 125. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Country (2027-2032) & (USD Million)
Table 126. Monoclonal Antibodies for Plaque Psoriasis Raw Material
Table 127. Key Manufacturers of Monoclonal Antibodies for Plaque Psoriasis Raw Materials
Table 128. Monoclonal Antibodies for Plaque Psoriasis Typical Distributors
Table 129. Monoclonal Antibodies for Plaque Psoriasis Typical Customers
Table 1. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 3. Janssen Biotech, Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Janssen Biotech, Inc. Major Business
Table 5. Janssen Biotech, Inc. Monoclonal Antibodies for Plaque Psoriasis Product and Services
Table 6. Janssen Biotech, Inc. Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 7. Janssen Biotech, Inc. Recent Developments/Updates
Table 8. Biocon Ltd. Basic Information, Manufacturing Base and Competitors
Table 9. Biocon Ltd. Major Business
Table 10. Biocon Ltd. Monoclonal Antibodies for Plaque Psoriasis Product and Services
Table 11. Biocon Ltd. Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Biocon Ltd. Recent Developments/Updates
Table 13. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 14. Novartis AG Major Business
Table 15. Novartis AG Monoclonal Antibodies for Plaque Psoriasis Product and Services
Table 16. Novartis AG Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Novartis AG Recent Developments/Updates
Table 18. Eli Lilly & Co. Basic Information, Manufacturing Base and Competitors
Table 19. Eli Lilly & Co. Major Business
Table 20. Eli Lilly & Co. Monoclonal Antibodies for Plaque Psoriasis Product and Services
Table 21. Eli Lilly & Co. Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Eli Lilly & Co. Recent Developments/Updates
Table 23. Bausch Health Cos., Inc Basic Information, Manufacturing Base and Competitors
Table 24. Bausch Health Cos., Inc Major Business
Table 25. Bausch Health Cos., Inc Monoclonal Antibodies for Plaque Psoriasis Product and Services
Table 26. Bausch Health Cos., Inc Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 27. Bausch Health Cos., Inc Recent Developments/Updates
Table 28. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 29. Sun Pharmaceutical Industries Ltd. Major Business
Table 30. Sun Pharmaceutical Industries Ltd. Monoclonal Antibodies for Plaque Psoriasis Product and Services
Table 31. Sun Pharmaceutical Industries Ltd. Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 32. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 33. Almirall SA Basic Information, Manufacturing Base and Competitors
Table 34. Almirall SA Major Business
Table 35. Almirall SA Monoclonal Antibodies for Plaque Psoriasis Product and Services
Table 36. Almirall SA Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 37. Almirall SA Recent Developments/Updates
Table 38. AbbVie, Inc. Basic Information, Manufacturing Base and Competitors
Table 39. AbbVie, Inc. Major Business
Table 40. AbbVie, Inc. Monoclonal Antibodies for Plaque Psoriasis Product and Services
Table 41. AbbVie, Inc. Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 42. AbbVie, Inc. Recent Developments/Updates
Table 43. UCB, Inc. Basic Information, Manufacturing Base and Competitors
Table 44. UCB, Inc. Major Business
Table 45. UCB, Inc. Monoclonal Antibodies for Plaque Psoriasis Product and Services
Table 46. UCB, Inc. Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 47. UCB, Inc. Recent Developments/Updates
Table 48. Chongqing Genrix Biopharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 49. Chongqing Genrix Biopharmaceutical Co., Ltd Major Business
Table 50. Chongqing Genrix Biopharmaceutical Co., Ltd Monoclonal Antibodies for Plaque Psoriasis Product and Services
Table 51. Chongqing Genrix Biopharmaceutical Co., Ltd Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 52. Chongqing Genrix Biopharmaceutical Co., Ltd Recent Developments/Updates
Table 53. Jiangsu Hengrui Pharmaceuticals Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 54. Jiangsu Hengrui Pharmaceuticals Co., Ltd Major Business
Table 55. Jiangsu Hengrui Pharmaceuticals Co., Ltd Monoclonal Antibodies for Plaque Psoriasis Product and Services
Table 56. Jiangsu Hengrui Pharmaceuticals Co., Ltd Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 57. Jiangsu Hengrui Pharmaceuticals Co., Ltd Recent Developments/Updates
Table 58. Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Manufacturer (2021-2026) & (K Units)
Table 59. Global Monoclonal Antibodies for Plaque Psoriasis Revenue by Manufacturer (2021-2026) & (USD Million)
Table 60. Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 61. Market Position of Manufacturers in Monoclonal Antibodies for Plaque Psoriasis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 62. Head Office and Monoclonal Antibodies for Plaque Psoriasis Production Site of Key Manufacturer
Table 63. Monoclonal Antibodies for Plaque Psoriasis Market: Company Product Type Footprint
Table 64. Monoclonal Antibodies for Plaque Psoriasis Market: Company Product Application Footprint
Table 65. Monoclonal Antibodies for Plaque Psoriasis New Market Entrants and Barriers to Market Entry
Table 66. Monoclonal Antibodies for Plaque Psoriasis Mergers, Acquisition, Agreements, and Collaborations
Table 67. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 68. Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Region (2021-2026) & (K Units)
Table 69. Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Region (2027-2032) & (K Units)
Table 70. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Region (2021-2026) & (USD Million)
Table 71. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Region (2027-2032) & (USD Million)
Table 72. Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Region (2021-2026) & (US$/Unit)
Table 73. Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Region (2027-2032) & (US$/Unit)
Table 74. Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2021-2026) & (K Units)
Table 75. Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2027-2032) & (K Units)
Table 76. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Type (2021-2026) & (USD Million)
Table 77. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Type (2027-2032) & (USD Million)
Table 78. Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Type (2021-2026) & (US$/Unit)
Table 79. Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Type (2027-2032) & (US$/Unit)
Table 80. Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2021-2026) & (K Units)
Table 81. Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2027-2032) & (K Units)
Table 82. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Application (2021-2026) & (USD Million)
Table 83. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Application (2027-2032) & (USD Million)
Table 84. Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Application (2021-2026) & (US$/Unit)
Table 85. Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Application (2027-2032) & (US$/Unit)
Table 86. North America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2021-2026) & (K Units)
Table 87. North America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2027-2032) & (K Units)
Table 88. North America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2021-2026) & (K Units)
Table 89. North America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2027-2032) & (K Units)
Table 90. North America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Country (2021-2026) & (K Units)
Table 91. North America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Country (2027-2032) & (K Units)
Table 92. North America Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Country (2021-2026) & (USD Million)
Table 93. North America Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Country (2027-2032) & (USD Million)
Table 94. Europe Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2021-2026) & (K Units)
Table 95. Europe Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2027-2032) & (K Units)
Table 96. Europe Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2021-2026) & (K Units)
Table 97. Europe Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2027-2032) & (K Units)
Table 98. Europe Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Country (2021-2026) & (K Units)
Table 99. Europe Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Country (2027-2032) & (K Units)
Table 100. Europe Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Country (2021-2026) & (USD Million)
Table 101. Europe Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Country (2027-2032) & (USD Million)
Table 102. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2021-2026) & (K Units)
Table 103. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2027-2032) & (K Units)
Table 104. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2021-2026) & (K Units)
Table 105. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2027-2032) & (K Units)
Table 106. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Region (2021-2026) & (K Units)
Table 107. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Region (2027-2032) & (K Units)
Table 108. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Region (2021-2026) & (USD Million)
Table 109. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Region (2027-2032) & (USD Million)
Table 110. South America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2021-2026) & (K Units)
Table 111. South America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2027-2032) & (K Units)
Table 112. South America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2021-2026) & (K Units)
Table 113. South America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2027-2032) & (K Units)
Table 114. South America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Country (2021-2026) & (K Units)
Table 115. South America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Country (2027-2032) & (K Units)
Table 116. South America Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Country (2021-2026) & (USD Million)
Table 117. South America Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Country (2027-2032) & (USD Million)
Table 118. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2021-2026) & (K Units)
Table 119. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Type (2027-2032) & (K Units)
Table 120. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2021-2026) & (K Units)
Table 121. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Application (2027-2032) & (K Units)
Table 122. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Country (2021-2026) & (K Units)
Table 123. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Sales Quantity by Country (2027-2032) & (K Units)
Table 124. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Country (2021-2026) & (USD Million)
Table 125. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Country (2027-2032) & (USD Million)
Table 126. Monoclonal Antibodies for Plaque Psoriasis Raw Material
Table 127. Key Manufacturers of Monoclonal Antibodies for Plaque Psoriasis Raw Materials
Table 128. Monoclonal Antibodies for Plaque Psoriasis Typical Distributors
Table 129. Monoclonal Antibodies for Plaque Psoriasis Typical Customers
LIST OF FIGURES
Figure 1. Monoclonal Antibodies for Plaque Psoriasis Picture
Figure 2. Global Monoclonal Antibodies for Plaque Psoriasis Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Monoclonal Antibodies for Plaque Psoriasis Revenue Market Share by Type in 2025
Figure 4. 5-100 mg/mL Examples
Figure 5. 100-200 mg/mL Examples
Figure 6. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Monoclonal Antibodies for Plaque Psoriasis Revenue Market Share by Application in 2025
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Others Examples
Figure 11. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 12. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 13. Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (2021-2032) & (K Units)
Figure 14. Global Monoclonal Antibodies for Plaque Psoriasis Price (2021-2032) & (US$/Unit)
Figure 15. Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Manufacturer in 2025
Figure 16. Global Monoclonal Antibodies for Plaque Psoriasis Revenue Market Share by Manufacturer in 2025
Figure 17. Producer Shipments of Monoclonal Antibodies for Plaque Psoriasis by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 18. Top 3 Monoclonal Antibodies for Plaque Psoriasis Manufacturer (Revenue) Market Share in 2025
Figure 19. Top 6 Monoclonal Antibodies for Plaque Psoriasis Manufacturer (Revenue) Market Share in 2025
Figure 20. Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Region (2021-2032)
Figure 21. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value Market Share by Region (2021-2032)
Figure 22. North America Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 23. Europe Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 24. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 25. South America Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 26. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 27. Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Type (2021-2032)
Figure 28. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value Market Share by Type (2021-2032)
Figure 29. Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Type (2021-2032) & (US$/Unit)
Figure 30. Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Application (2021-2032)
Figure 31. Global Monoclonal Antibodies for Plaque Psoriasis Revenue Market Share by Application (2021-2032)
Figure 32. Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Application (2021-2032) & (US$/Unit)
Figure 33. North America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Type (2021-2032)
Figure 34. North America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Application (2021-2032)
Figure 35. North America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Country (2021-2032)
Figure 36. North America Monoclonal Antibodies for Plaque Psoriasis Consumption Value Market Share by Country (2021-2032)
Figure 37. United States Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 38. Canada Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 39. Mexico Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Type (2021-2032)
Figure 41. Europe Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Application (2021-2032)
Figure 42. Europe Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Country (2021-2032)
Figure 43. Europe Monoclonal Antibodies for Plaque Psoriasis Consumption Value Market Share by Country (2021-2032)
Figure 44. Germany Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 45. France Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 46. United Kingdom Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 47. Russia Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 48. Italy Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 49. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Type (2021-2032)
Figure 50. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Application (2021-2032)
Figure 51. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Region (2021-2032)
Figure 52. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Consumption Value Market Share by Region (2021-2032)
Figure 53. China Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 54. Japan Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 55. South Korea Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 56. India Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 57. Southeast Asia Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 58. Australia Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 59. South America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Type (2021-2032)
Figure 60. South America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Application (2021-2032)
Figure 61. South America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Country (2021-2032)
Figure 62. South America Monoclonal Antibodies for Plaque Psoriasis Consumption Value Market Share by Country (2021-2032)
Figure 63. Brazil Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 64. Argentina Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 65. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Type (2021-2032)
Figure 66. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Application (2021-2032)
Figure 67. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Country (2021-2032)
Figure 68. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Consumption Value Market Share by Country (2021-2032)
Figure 69. Turkey Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 70. Egypt Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 71. Saudi Arabia Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 72. South Africa Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 73. Monoclonal Antibodies for Plaque Psoriasis Market Drivers
Figure 74. Monoclonal Antibodies for Plaque Psoriasis Market Restraints
Figure 75. Monoclonal Antibodies for Plaque Psoriasis Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Monoclonal Antibodies for Plaque Psoriasis in 2025
Figure 78. Manufacturing Process Analysis of Monoclonal Antibodies for Plaque Psoriasis
Figure 79. Monoclonal Antibodies for Plaque Psoriasis Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Monoclonal Antibodies for Plaque Psoriasis Picture
Figure 2. Global Monoclonal Antibodies for Plaque Psoriasis Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Monoclonal Antibodies for Plaque Psoriasis Revenue Market Share by Type in 2025
Figure 4. 5-100 mg/mL Examples
Figure 5. 100-200 mg/mL Examples
Figure 6. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 7. Global Monoclonal Antibodies for Plaque Psoriasis Revenue Market Share by Application in 2025
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Others Examples
Figure 11. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 12. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 13. Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity (2021-2032) & (K Units)
Figure 14. Global Monoclonal Antibodies for Plaque Psoriasis Price (2021-2032) & (US$/Unit)
Figure 15. Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Manufacturer in 2025
Figure 16. Global Monoclonal Antibodies for Plaque Psoriasis Revenue Market Share by Manufacturer in 2025
Figure 17. Producer Shipments of Monoclonal Antibodies for Plaque Psoriasis by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 18. Top 3 Monoclonal Antibodies for Plaque Psoriasis Manufacturer (Revenue) Market Share in 2025
Figure 19. Top 6 Monoclonal Antibodies for Plaque Psoriasis Manufacturer (Revenue) Market Share in 2025
Figure 20. Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Region (2021-2032)
Figure 21. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value Market Share by Region (2021-2032)
Figure 22. North America Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 23. Europe Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 24. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 25. South America Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 26. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 27. Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Type (2021-2032)
Figure 28. Global Monoclonal Antibodies for Plaque Psoriasis Consumption Value Market Share by Type (2021-2032)
Figure 29. Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Type (2021-2032) & (US$/Unit)
Figure 30. Global Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Application (2021-2032)
Figure 31. Global Monoclonal Antibodies for Plaque Psoriasis Revenue Market Share by Application (2021-2032)
Figure 32. Global Monoclonal Antibodies for Plaque Psoriasis Average Price by Application (2021-2032) & (US$/Unit)
Figure 33. North America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Type (2021-2032)
Figure 34. North America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Application (2021-2032)
Figure 35. North America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Country (2021-2032)
Figure 36. North America Monoclonal Antibodies for Plaque Psoriasis Consumption Value Market Share by Country (2021-2032)
Figure 37. United States Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 38. Canada Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 39. Mexico Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Type (2021-2032)
Figure 41. Europe Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Application (2021-2032)
Figure 42. Europe Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Country (2021-2032)
Figure 43. Europe Monoclonal Antibodies for Plaque Psoriasis Consumption Value Market Share by Country (2021-2032)
Figure 44. Germany Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 45. France Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 46. United Kingdom Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 47. Russia Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 48. Italy Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 49. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Type (2021-2032)
Figure 50. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Application (2021-2032)
Figure 51. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Region (2021-2032)
Figure 52. Asia-Pacific Monoclonal Antibodies for Plaque Psoriasis Consumption Value Market Share by Region (2021-2032)
Figure 53. China Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 54. Japan Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 55. South Korea Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 56. India Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 57. Southeast Asia Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 58. Australia Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 59. South America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Type (2021-2032)
Figure 60. South America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Application (2021-2032)
Figure 61. South America Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Country (2021-2032)
Figure 62. South America Monoclonal Antibodies for Plaque Psoriasis Consumption Value Market Share by Country (2021-2032)
Figure 63. Brazil Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 64. Argentina Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 65. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Type (2021-2032)
Figure 66. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Application (2021-2032)
Figure 67. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Sales Quantity Market Share by Country (2021-2032)
Figure 68. Middle East & Africa Monoclonal Antibodies for Plaque Psoriasis Consumption Value Market Share by Country (2021-2032)
Figure 69. Turkey Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 70. Egypt Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 71. Saudi Arabia Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 72. South Africa Monoclonal Antibodies for Plaque Psoriasis Consumption Value (2021-2032) & (USD Million)
Figure 73. Monoclonal Antibodies for Plaque Psoriasis Market Drivers
Figure 74. Monoclonal Antibodies for Plaque Psoriasis Market Restraints
Figure 75. Monoclonal Antibodies for Plaque Psoriasis Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Monoclonal Antibodies for Plaque Psoriasis in 2025
Figure 78. Manufacturing Process Analysis of Monoclonal Antibodies for Plaque Psoriasis
Figure 79. Monoclonal Antibodies for Plaque Psoriasis Industrial Chain
Figure 80. Sales Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
